Asimov has launched its AAV Edge Stable Producer system, delivering clonal HEK293 stable cell lines that harbor essential viral genes for adeno-associated virus (AAV) vector manufacturing. These producer lines eliminate reliance on transient transfection of GMP plasmids, mitigating supply risks, lowering costs, and improving batch consistency. With titers up to 6x10^15 vector genomes per liter, Asimov’s platform aims to support scalable, cost-effective production of high-quality AAV gene therapies at industrial scales.